"Virus infections pose significant global health challenges, especially in view of the fact that the emergence of resistant viral strains and the adverse side effects associated with prolonged use continue to slow down the application of effective antiviral therapies. This makes imperative the need for the development of safe and potent alternatives to conventional antiviral drugs."
https://pubmed.ncbi.nlm.nih.gov/22024958/
"Considerable efforts have focused on developing metal nanoparticles for the treatment of several pathogenic viruses. As a result of these efforts, metal nanoparticles are demonstrating promising antiviral activity against pathogenic surrogates and clinical isolates."
https://pubmed.ncbi.nlm.nih.gov/33029761/
"Metal nanoparticles due to their intrinsic structural and functional properties, not only contribute to anti-viral properties but also help to reduce the risk for associated complications."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113381/
"According to existing research, metal NPs have already proven to be active antiviral agents against human immunodeficiency virus (HIV), influenza virus, hepatitis virus, etc. [1, 6]."
https://link.springer.com/article/10.1007/s12011-020-02414-2